insights_auto
Why is ALCOX down 2,10%?
Dive Deeperchevron_right
ALCOX:EPA
NicOx SA
0,30 €
arrow_downward
-2,10%(-0,0065) 1D
12 қаз., 17:35:10 GMT+2 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ALCOX...
Open
0,31 €
High
0,31 €
Low
0,30 €
Mkt. cap
34,60 млн
Avg. vol.
164,58 м.
Volume
116,36 м.
52-wk high
0,57 €
52-wk low
0,28 €
EPS
-0,03 €
Shares outstanding
97,55 млн
No. of employees
10
Open
0,31 €
High
0,31 €
Low
0,30 €
Mkt. cap
34,60 млн
Avg. vol.
164,58 м.
Volume
116,36 м.
52-wk high
0,57 €
52-wk low
0,28 €
EPS
-0,03 €
Shares outstanding
97,55 млн
No. of employees
10
News stories
From web sources and news partners
GlobeNewswire
·
42 минут бұрын
LifeVantage Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
The Business Journals
·
1 сағат бұрын
Axe Compute rings Nasdaq bell after pivoting from biotech to AI tokens
Seeking Alpha
·
36 минут бұрын
3 things to look out for on Tuesday (SP500:)
Profile
Nicox S.A. is a French ophthalmology company developing treatments to maintain vision and improve ocular health. Nicox is headquartered in Sophia Antipolis, France, and its Chairman and CEO is Michele Garufi.
Nicox is listed on Euronext Paris and is part of the CAC Healthcare, CAC Pharma & Bio and Next 150 indexes. Its pipeline includes three programs in development, and it has two U.S. Food and Drug Administration approved products. Wikipedia
About NicOx SA
CEO-
Employees10
Founded1996
HeadquartersValbonne, Provence-Alpes-Côte d'Azur, Франция
Sector-
Websitenicox.com